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Gastric cancer is the world’s second most common cause of cancer death. We analyzed gene
expression patterns in 90 primary gastric cancers, 14 metastatic gastric cancers, and 22 nonneo-
plastic gastric tissues, using cDNA microarrays representing 30,300 genes. Gastric cancers were
distinguished from nonneoplastic gastric tissues by characteristic differences in their gene expres-
sion patterns. We found a diversity of gene expression patterns in gastric cancer, reflecting
variation in intrinsic properties of tumor and normal cells and variation in the cellular composi-
tion of these complex tissues. We identified several genes whose expression levels were signifi-
cantly correlated with patient survival. The variations in gene expression patterns among cancers
in different patients suggest differences in pathogenetic pathways and potential therapeutic
strategies.
INTRODUCTION
Gastric cancer is the second most common cause of cancer
death worldwide (Parkin et al., 1999). Environmental and
genetic factors are both important in gastric carcinogenesis.
Gastritis, most commonly due to Helicobacter pylori infection,
is strongly associated with development of gastric cancer
(Parsonnet et al., 1991). In a small fraction of gastric cancers,
the cancer cells have been found to be latently infected by
Epstein-Barr virus (EBV; Shibata and Weiss, 1992). Intestinal
metaplasia in response to chronic inflammation often pre-
cedes development of gastric cancer and may be an impor-
tant precursor (Correa, 1988). The Lauren classification,
which distinguishes tumors based on their histological ap-
pearance into “intestinal” and “diffuse” types, has proven to
be clinically useful (Lauren, 1965). These two histological
types have been proposed to be related to differences in
pathogenetic mechanisms (Lauren, 1965; Grabiec and Owen,
1985).
The prognosis of gastric cancer depends heavily on tumor
stage at diagnosis. Surgical resection, still the mainstay of
treatment, is very effective in early stage cancer. Most pa-
tients present in advanced stages, however, when the prog-
nosis is extremely poor. Recent studies have shown that
comprehensive analysis of gene expression patterns can
identify new molecular criteria for classification and prog-
nostication of diverse cancers. The molecular portraits pro-
vided by the tumors’ gene expression patterns provide a
basis for recognizing new subtypes of cancer that, although
morphologically indistinguishable, differ in clinical behav-
ior, molecular pathways of tumor development, and under-
lying genetic predisposition (Alizadeh et al., 2000; Perou et
al., 2000; Dhanasekaran et al., 2001; Garber et al., 2001; He-
denfalk et al., 2001; Rosenwald et al., 2001; Sorlie et al., 2001;
Pomeroy et al., 2002; Rosenwald et al., 2002; van ‘t Veer et al.,
2002).
Previous studies have reported expression profiles in
small numbers of gastric cancer samples, identifying a few
hundred genes that distinguish tumor from normal tissue
(El-Rifai et al., 2001; Hippo et al., 2002). However, these
studies were too small to distinguish subgroups or identify
any genes whose expression may be correlated with clinical
outcomes. Here we describe a systematic study of gene
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expression patterns in gastric adenocarcinomas and nonneo-
plastic gastric mucosa. The results define potential molecu-
lar criteria for disease classification, early detection, and
prognostication as well as providing new insights into the
pathogenesis and progression of gastric cancers.
MATERIALS AND METHODS
Samples and RNA Preparation
Samples of tumor and normal gastric mucosa were collected from
gastrectomy specimens from Department of Surgery, Queen Mary
Hospital, The University of Hong Kong. Tissues were frozen in
liquid nitrogen within half an hour after they were resected. Non-
neoplastic mucosa from stomach, small intestine, and colon was
dissected free of muscle and histologically confirmed to be tumor
free by frozen section. Total RNA was extracted using Trizol (In-
vitrogen, Carlsbad, CA) and mRNA was isolated by the FastTrack
mRNA isolation kit (Invitrogen). This study was approved by the
Ethics Committee of the University of Hong Kong and the IRB from
Stanford University.
Tumors were classified using the Lauren’s classification into in-
testinal, diffuse, mixed and indeterminate types (Lauren, 1965). The
presence of H. pylori in the gastrectomy specimens was determined
by histological examination, supplemented by modified Giemsa
staining. The presence of EBV in cancer cells was assayed by in situ
hybridization for EBER as described previously (Yuen et al., 1994).
The tumor stage was defined by the General Rules for Gastric
Cancer Study of the Japanese Research Society for Gastric Cancer
(Nishi et al., 1995).
Microarray Procedure and Data Analysis
We used cDNAs microarray containing 44,500 cDNA clones, repre-
senting 30,300 unique genes. The methods for microarray produc-
tion and hybridization, and data analysis, including hierarchical
clustering, closely followed previously described procedures (Aliza-
deh et al., 2000; Perou et al., 2000). In brief, 2 g of sample mRNA
and 2 g of reference mRNA were used as template for synthesis of
cDNA, labeled with Cy5-dUTP and Cy3-dUTP (Amersham, Pisca-
taway, NJ), respectively, using reverse transcriptase (Invitrogen) for
2 h at 42°C. The two labeled cDNA samples were separated from
unincorporated nucleotides by filtration, mixed, and hybridized to
microarray at 65°C overnight. After hybridization, each microarray
was washed with 2 SSC, 0.03% SDS for 5 min at 65°C and then
with 1 SSC for 5 min and 0.1 SSC for 5 min, both at room
temperature. The array was then scanned with a GenePix 4000B
microarray scanner (Axon Instruments, Union City, CA). Primary
data collection and analysis were carried out using GenePix Pro3.0
(Axon Instruments). Areas of the array with obvious blemishes
were manually flagged and excluded from subsequent analysis. The
raw data were deposited into Stanford Microarray Database (Sher-
lock et al., 2001) at: http://genome-www4.stanford.edu/MicroAr-
ray/SMD/index.html.
Statistical Analysis
We selected nonflagged array elements for which the fluorescent
intensity in either channel was greater than 3 times the local back-
ground. Genes for which fewer than 80% of measurements met this
standard, across all the samples in this study, were excluded from
the analysis. We further selected genes whose expression level
differed by at least 2.5-fold, in at least three samples, from their
mean expression level across all samples for hierarchial clustering.
Before the statistical analysis, the missing values in the dataset were
estimated by a KNN impute algorithm using 12 neighbors (Troy-
anskaya et al., 2001). A nonparametric t test with p value cutoff of
0.001 or 0.002 based on 10,000 random column permutations was
used to identify genes differentially expressed in gastric cancer and
nonneoplastic gastric tissue samples (Troyanskaya et al., 2002). The
false discovery rate (FDR) was estimated based on the number of
genes that passed the p value cutoff of 0.001 or 0.002 in five datasets
with randomized columns. Cox regression survival analysis was
performed to identify genes whose expression levels correlated with
patient survival, using the Cox regression function in the statistical
package R (http://lib.stat.cmu.edu/R/CRAN). The p value reflect-
ing the correlation of each gene’s expression pattern with patient
survival was calculated individually using the Cox function in SPSS,
without adjustment for multiple testing, therefore, the p values
presented in the article might overestimate statistical significance
because of multiple hypothesis testing.
RESULTS AND DISCUSSION
Using a cDNA microarray containing 44,500 clones, repre-
senting 30,300 different genes, we profiled mRNA popu-
lations in 90 primary gastric adenocarcinomas, lymph node
metastases from 14 of the same 90 tumors, and 22 samples of
nonneoplastic gastric mucosa adjacent from resected tu-
mors, representing both antrum (12 samples) and body (10
samples). Among the 12 antral tissues, 7 showed intestinal
metaplasia. From the roughly 30,000 genes whose expres-
sion was measured in these samples, we identified a set of
5200 genes whose transcripts varied by at least 2.5-fold
from their mean abundance in the sample set, in at least 3
samples (Figure 1). We used a hierarchical clustering
method to group these genes on the basis of similarity in
expression across the samples and to group samples based
on similarity in their gene expression patterns.
Heterogeneity of the Gene Expression Patterns
among Gastric Cancer Tissues
Simple hierarchical clustering analysis readily segregated
nontumor samples from all the tumors and revealed com-
plex variations in gene expression patterns among the gas-
tric cancers. Eleven of the 14 lymph node metastases were
clustered with primary tumor from which they arose, im-
plying that the gene expression patterns in the metastatic
tumor masses were more similar to the patterns in the
corresponding primary tumors than to any of the other
metastatic or primary tumors. The three exceptions were
attributable to differences between the primary and meta-
static tumors in the admixture of nontumor cells; when
hierarchical clustering of the tumors was carried out based
on expression of set of genes that excluded genes character-
istically expressed in lymphocytes and stromal cells, all 14
pairs of primary and metastatic tumors from the same pa-
tient clustered together as nearest neighbors (see Web sup-
plement). This result implies that each gastric cancer has a
unique characteristic gene expression pattern and that the
distinctive features of these molecular portraits are main-
tained even when tumors metastasize to the lymph node.
We can use these 14 paired samples to identify a set of
“intrinsic genes,” whose expression levels vary widely
among tumors from different patients, but are closely
matched in primary and metastatic tumors from the same
patient. These genes are likely to be especially useful for
recognition of molecular subtypes of gastric cancer (Perou et
al., 2000; see Web supplement).
Genes with consistent differences in expression between
the gastric cancer and the nonneoplastic gastric tissues are of
particular interest. Using a nonparametric t test, we identi-
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fied 2656 genes whose expression levels were significantly
different between tumor and normal tissues, with p  0.001
and a false discovery rate of 0.13% (see Web supplement).
A cluster of2000 genes was expressed at higher levels in
most of gastric cancers compared with nontumor tissues
(Figure 1). Among these 2000 genes were a group of genes
associated with cell cycle progression, the “proliferation
cluster” (Iyer et al., 1999; Whitfield et al., 2002), whose tran-
scripts were generally much more abundant in the tumors
than in nonneoplastic tissues, though their levels varied
considerably among the tumor samples (Figure 2c).
Several clusters of genes that appear to reflect primary
events important for gastric carcinogenesis, such as chromo-
somal amplifications or alterations in transcriptional regula-
tors or signal transduction pathways, were specifically asso-
ciated with subsets of these cancers. For example, cyclinE1,
POP4, RMP, UQCRFS1, and DKFZP762D096 were coex-
pressed at greatly elevated levels in 10% of gastric tumors
(Figure 2a). All these genes are located on chromosome
19q12-13, suggesting amplification of a locus containing Cy-
clinE1 in this group of tumors. Similarly, in10% of tumors,
a cluster of genes including ErbB2 and two neighboring
genes on chromosome 17q12-21 (Grb7 and MLN64), showed
markedly elevated expression, strongly suggesting amplifi-
cation of the ErbB2 locus in these tumors (Figure 2b).
Another cluster of genes jointly expressed at elevated
levels in some gastric cancers included AXIN2 and beta-
catenin (Figure 2d). AXIN2 is induced by beta-catenin/TCF
as part of an auto-regulatory pathway in Wnt signaling.
Colorectal and liver tumors with activation of the Wnt sig-
naling pathway have been shown consistently to express a
high level of AXIN2 (Lustig et al., 2002). Activation of this
pathway by mutations in APC or beta-catenin leads to in-
creased levels of beta-catenin and its nuclear localization
(Korinek et al., 1997). Indeed, immunohistochemical staining
revealed nuclear beta-catenin in many of the gastric tumors
Figure 1. Hierarchical clustering of the pat-
terns of variation in expression of 5200 genes
in 90 gastric tumors, 14 paired lymph node
metastasis, and 22 nonneoplastic gastric mu-
cosa. Each row represents a separate cDNA
clone on the microarray and each column a
separate mRNA sample. In each gastric tissue
sample, the ratio of abundance of transcripts
of each gene to its mean abundance across all
tissue samples is depicted according to the
color scale shown at the bottom. Gray indi-
cates missing or excluded data. The dendro-
gram at the top provides a measure of the
relatedness of gene expression in each sample
and is color coded according to the category of
mRNA sample studied. The dendrogram at
the top of the figure represents the hierarchical
clustering of the tumors based on similarity in
their pattern of expression of these genes. See
supplementary information for full data.
X. Chen et al.
Molecular Biology of the Cell3210
that express high levels of AXIN2 (see Web supplement).
Abnormal activation of the Wnt pathway may therefore play
a role in the pathogenesis of this distinct subgroup of gastric
tumors. This gene cluster also included EphB2, a member of
the Eph receptor tyrosine kinases. Ephrin signaling has been
shown to be important in embryonic development, includ-
ing axon guidance and angiogenesis (Kullander and Klein,
2002). This pathway has also been implicated in promoting
tumorgenesis (Dodelet and Pasquale, 2000). A recent study
showed that the activation of beta-catenin led to high expres-
sion of EphB receptors and that expression of EphB is crucial
for the correct positioning of epithelial cells in gut (Batlle et al.,
2002). It is therefore interesting to note that EphB2 coclustered
with beta-catenin and AXIN2 because of its patterns of expres-
sion in these gastric cancer tissues. The relationship of expres-
sion of EphB and Wnt signaling pathways in gastric cancer
development deserves further investigation.
Clusters of genes that were generally more highly expressed
in normal gastric mucosa than in gastric cancers are also of
considerable interest (Figure 2, e and f). Among them, many
are known to have role in the digestive function of the stomach
or the integrity of the mucosa, such as pepsinogen C, carbonic
anhydrase II, specific subtypes of gastric mucins (MUC5AC
and MUC6) and somatostatin. Some putative tumor suppres-
sor genes or genes with known growth inhibitory effects in the
gastrointestinal tract can also be found in this cluster. These
include TFF1—mice lacking TFF1 develop gastric adenomas
and intramucosal carcinomas (Lefebvre et al., 1996)—and
CDKN1C, the gene encoding the p57KIP2 cyclin-dependent
kinase inhibitor, whose promoter has been found to be meth-
ylated, accompanied by transcriptional silencing, in some gas-
tric cancer cell lines (Shin et al., 2000).
Gastric cancer is a histologically complex tissue. The recip-
rocal interactions between tumor cells and stromal cells play
important roles in tumor biology. A cluster of genes, including
many that encode extracellular matrix components, appears to
reflect variation in the proportion of stromal cells in the tumor.
The genes in this cluster tend to be significantly more highly
expressed in tumors of the diffuse histological type than in
tumors of the intestinal type (see Web supplement), consistent
with greater propensity of this group of tumors for invasive
growth, often provoking a dense fibrous reaction. The expres-
sion patterns of two clusters of genes, which we term the
“leukocyte” and “interferon” clusters, respectively, appear to
Figure 2. Features of the variation in gene
expression patterns can be related to specific
physiological and genotypic variations in the
tumor and nontumor tissue samples. Data are
the same as in Figure 1. Selected gene clusters
(a–d) illustrate coordinated variation in ex-
pression of genes in tumor samples, reflecting
apparent variation in signaling pathways,
chromosomal amplification, or cell prolifera-
tion. (a) Cyclin E cluster; (b) ErbB2 cluster; (c)
proliferation cluster; (d) AXIN cluster. Genes
depicted in the normal cluster (e and f) reflect
loss of specialized gastric functional compo-
nent as well as reduced expression of putative
tumor suppressor gene or cell cycle inhibitor
in the tumor samples.
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reflect the density, composition, and physiology of infiltrating
leukocytes. The genes in these two clusters were generally
significantly more highly expressed in the EBV-associated tu-
mors (see Web supplement), consistent with previous reports
that these EBV-associated gastric cancers are often, though not
invariably, accompanied by intense lymphoid infiltrate. A clus-
ter of genes that included immunoglobulin genes was ex-
pressed at high levels in gastric mucosa and in some tumors,
and their expression correlated well with the number of
plasma cells as determined by histological examination (see
Web supplement). Similarly, a cluster enriched in genes char-
acteristically expressed by smooth muscle appears to reflect
adventitious smooth muscle cells in the samples (see Web
supplement).
A Gene Expression Pattern Associated with
Intestinal Metaplasia Defines a Distinct Subset of
Gastric Cancers
Gastric cancers frequently arise in a background of chronic
gastritis with intestinal metaplasia. As a step toward under-
standing this relationship, we explored the variations in
gene expression patterns in different anatomical regions of
the normal stomach, in metaplastic gastric mucosa, and in
Figure 3. Expanded view of the gastric body-specific gene cluster (a), intestinal metabolism gene cluster (b), and intestinal differentiation
gene cluster (c). Expression patterns of the same genes in small intestine and colon are depicted in the right panel for comparison. (d)
Discovery of gastric cancer subtypes by expression of intestinal differentiation gene cluster. Hierarchical clustering of gastric cancer based on
the genes of the intestinal differentiation signature shown in c. Two GC subgroups, “intestinal-like” (pink) and “gastric-like” (purple) were
defined by this process. Associations with histological features or etiological agents are depicted by color-coded box below the dendrogram.
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samples of normal mucosa from small intestine and colon
(displayed to the right of the main cluster; Figure 3). Based
on their global gene expression patterns, the samples of
nonneoplastic gastric mucosa were segregated into three
branches, one corresponding to the gastric body and the
other two corresponding to antral mucosa with and without
intestinal metaplasia, respectively.
Three prominent gene clusters distinguished these three
different types of gastric mucosa. A group of genes were
expressed selectively in gastric body, but not in antrum,
small intestine or colon, nor, to any significant degree, in
gastric tumors (Figure 3a). This group included genes in-
volved in transport (KCNJ16) and proteolysis (PSMB9), pre-
sumably reflecting functional specialization of the mucosa of
the gastric body. A second cluster of genes, expressed at
high level in metaplastic mucosa, but very little in nonmeta-
plastic mucosa and most gastric tumors (Figure 3b), in-
cluded genes with roles in lipid (MTP, FABP1, APOA1),
amino acid (GGT1), or glucose (ALDOB) transport or me-
tabolism. Most of these genes are also highly expressed in
small intestine and to a lesser extent in the colon. The third
cluster of genes, also highly expressed in metaplastic antral
mucosa compared with nonmetaplastic gastric mucosa, ap-
pears to be related to the control of intestinal differentiation
(Figure 3c). Genes in this cluster include transcription factors
that are involved in inducing and maintaining differentia-
tion of the small and large intestine (CDX1, CDX2, and
HNF4A) as well as integral membrane proteins and adhe-
sion molecules that are characteristic of intestinal epithelium
(CLDN3, CLDN4, CDH17, and VIL1). The genes in this
cluster are expressed in small intestine and colon mucosa,
supporting their association with intestinal differentiation.
Surprisingly, this group of genes was also expressed at high
levels in many gastric cancers. On the basis of expression of
41 genes in the cluster, the 90 gastric cancer samples can be
segregated into two groups, which for the purpose of this
discussion, we labeled “intestinal-like” and “gastric-like”
(Figure 3d). We hypothesized that tumors showing intesti-
nal-like gene expression patterns were derived from gastric
mucosa cells that have undergone intestinal metaplasia.
Gastric cancer is traditionally classified into two subtypes
based on their histological architecture (Lauren, 1965). The
“intestinal type,” characterized by cohesive growth of cells
in quasi-glandular structures, has been presumed to arise
secondarily from intestinal metaplasia, whereas the “diffuse
type,” in which tumor cells were dispersed and generally
not organized into glandular structures, has been thought to
arise directly from nonmetaplastic foveolar or mucous neck
cells (Grabiec and Owen, 1985). We therefore explored the
relationship between expression of this intestinal differenti-
ation gene cluster and the two histologically defined cancer
subtypes. To our surprise, the intestinal-like gene expression
pattern was seen with equal frequency in the histologically
defined intestinal and diffuse groups (Figure 3d and Web
supplement). In contrast, there was a strong association
between the intestinal-like gene expression pattern and the
presence of intestinal metaplasia at the tumor edge (p 
0.001; Figure 3d and Web supplement). Our data therefore
suggest the possibility that the intestinal-like gastric cancers,
as defined based on their gene expression patterns, may
arise from gastric mucosal cells that have previously under-
gone intestinal metaplasia and thus retain the molecular
signature of the intestinal enterocyte, whereas the gastric-
like cancers may arise by alternative pathway that does not
involve intestinal metaplasia as an intermediate step. It will
be important in following up these results to focus for the
attention on the progression of events involved in metaspla-
sia and gastric cancer development.
Our identification of a transcriptional program related to
intestinal differentiation in gastric cancer provides one po-
tential basis for extending classification of gastric cancer
beyond morphological distinctions. Antibodies against pro-
teins encoded by genes in the “intestinal differentiation”
cluster may provide a convenient adjunct to conventional
histopathology in classifying gastric cancers. Because the
distinct molecular phenotypes of the intestinal-like and gas-
tric-like gastric cancers are likely to have counterparts in the
physiology and behavior of the tumors, recognition of these
differences may be of significant value in evaluating clinical
behavior and treatment trials.
Differential Expression of the Molecular Targets of
Potential Therapeutic Agents
Specific features of the gene expression programs that dis-
tinguish gastric cancers may not only provide clues to dif-
ferences in their regulation but may provide critical infor-
mation for individualized therapy using molecularly
targeted treatment modalities. For example, TACSTD1,
which encodes a homophilic calcium-independent cell ad-
hesion molecule, is among the genes characteristically ex-
pressed in the intestinal-like subset of gastric cancers. An
mAb (CO17–1A) against this protein has shown consider-
able promise in treatment of colorectal cancer in phase II/III
randomized clinical trials (Riethmuller et al., 1998). The dif-
ferential expression of this gene among gastric cancers sug-
gests its potential selective application in treatment of pa-
tients with intestinal-like gastric cancer. Similarly, the
elevated expression of the EGF receptor in 15% of gastric
cancers suggests that these patients may benefit from com-
pounds (both small molecular inhibitors and monoclonal
antibodies) that target this protein, which have shown
promise in clinical trials against a variety of cancers, and the
highly elevated expression of ErbB2 in a small but signifi-
cant fraction of gastric cancers raises the possibility that this
group of patients may benefit from treatment with Hercep-
tin.
Gene Expression Patterns and Infectious Etiologies
Despite the strong association between H. pylori infection
and gastric cancer, we were unable to identify genes whose
expression levels were significantly associated with H. pylori
infection. Although the intestinal-like gene expression pat-
tern was somewhat more common than the gastric-like pat-
tern in cancers associated with H. pylori infection, the differ-
ence was not statistically significant (see Web supplement).
The critical role that H. pylori infection can play in the
pathogenesis of gastric cancer may precede the development
of overt cancers by many years. Therefore, histological evi-
dence of contemporaneous H. pylori infection in the surgical
samples may not reflect the role this infection played in the
development of a tumor. It will be of great interest in future
studies to compare gene expression patterns in gastric can-
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cer with a more comprehensive assessment of the patient’s
past history of H. pylori infection.
The expression levels of 326 genes showed a significant
association with EBV infection (p 0.002, and FDR 5%;
see Web supplement). Some of these genes appeared to be
related to the lymphoid infiltrate often observed in EBV
gastric cancers. Among the 135 genes whose expression
tended to be significantly higher in the EBV cancers was
p53, consistent with previous reports of elevated p53 expres-
sion by a nonmutational mechanism in these tumors (Leung
et al., 1998; Wu et al., 2000). Interestingly, we found that most
(11/12) EBV-associated gastric cancers had the gastric-like
gene expression phenotype (p  0.007) (Figure 3d and Web
supplement), although most of these tumors would be clas-
sified as intestinal by histopathology. The role of EBV in the
pathogenesis of this distinct type of gastric cancer will be an
interesting question for future investigation.
Expression Patterns Significantly Correlated with
Patient Survival
We identified several genes whose expression levels in the
gastric cancer samples were significantly associated with
patient survival (see Web supplement). These genes define
molecular markers that may be immediately useful for prog-
nosis and treatment stratification. Clearly, it will be impor-
tant to corroborate the association between the expression of
these genes and patient survival in an independent sample
set. Some of these genes may play important roles in gastric
tumor progression. For example, a high level of expression
of IGF-2 was associated with poor patient survival (p 
0.002 by Cox regression assay). Overexpression of IGF-2 has
been implicated in progression and metastasis of many
types of cancers, including colon cancer, breast cancer,
Wilm’s tumor, and neuroblastoma (Toretsky and Helman,
1996). The potential involvement of IGF-2 in the progression
of gastric cancer clearly warrants further investigation. Pa-
tients whose gastric cancers expressed PLA2G2A, the gene
encoding the group IIa secreted phospholipase A2, at high
levels, had a highly significant survival advantage (p 
0.002). The murine ortholog of PLA2G2A, has been shown
genetically to limit the severity of intestinal neoplasia in the
Apcmin1/ mouse, a mouse model of familial adenomatous
polyposis, suggesting that PLA2G2A may play a similar role
in suppressing progression of human gastric cancer
(MacPhee et al., 1995; Cormier et al., 1997). A more extensive
analysis and discussion of the association between
PLA2G2A and gastric cancer progression is reported sepa-
rately (Leung et al., 2002).
In summary, a systematic study of gene expression pat-
terns in human gastric cancers has revealed inherent molec-
ular heterogeneity in gastric cancer, and identified multidi-
mensional variations in gene expression patterns that
distinguish gastric carcinoma and gastric mucosa in various
preneoplastic stages. By using both supervised and unsu-
pervised methods to search for relationships and systematic
patterns in the data and by comparison of the expression
patterns in the cancers with those seen in normal tissue of
various histological types, we can begin to place features of
this molecular variation into an interpretative framework
that provides insights into the biological features and poten-
tial clues to the pathogenesis of these cancers. Differences
among cancers in expression of specific genes may provide
strong predictors of prognosis and suggest the potential
utility of specific, molecularly targeted therapies.
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